← Open Payments lookup

ASHLEY BRYANT: Open Payments

NPI 1851075139 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,438 in 87 payments from 18 companies in 2025. Trend: 2023 $38 · 2024 $1,739 · 2025 $1,438

Food & beverage: $1,438
CompanyPaymentsAmount
ABBVIE INC.27$319
Novo Nordisk Inc20$260
Lilly USA, LLC7$146
AstraZeneca Pharmaceuticals LP6$113
Vanda Pharmaceuticals Inc.4$97
Bayer Healthcare Pharmaceuticals Inc.3$82
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$74
Otsuka America Pharmaceutical, Inc.3$70
Neurocrine BioSciences, Inc.2$55
Teva Pharmaceuticals USA, Inc.2$38

Products named: VRAYLAR, Wegovy, MOUNJARO, HETLIOZ, QULIPTA, REXULTI, Kerendia, Ozempic.

Industry payments across IN — which companies pay providers there.